The metabolic response to rapid intravenous glucose injection in acute falciparum malaria.

Because hypoglycaemia is common in severe malaria, intravenous glucose is often given empirically to patients on admission to hospital. To investigate the metabolic response to rapid glucose injection in acute malaria, 50 ml of 50% w/v (25 g) dextrose was given over 5 min to 10 adult patients (7 mal...

詳細記述

書誌詳細
主要な著者: Pukrittayakamee, S, Davis, T, Levy, J, Looareesuwan, S, Roche, R, Jeerawathanapun, P, White, N
フォーマット: Journal article
言語:English
出版事項: 1991
_version_ 1826278697754165248
author Pukrittayakamee, S
Davis, T
Levy, J
Looareesuwan, S
Roche, R
Jeerawathanapun, P
White, N
author_facet Pukrittayakamee, S
Davis, T
Levy, J
Looareesuwan, S
Roche, R
Jeerawathanapun, P
White, N
author_sort Pukrittayakamee, S
collection OXFORD
description Because hypoglycaemia is common in severe malaria, intravenous glucose is often given empirically to patients on admission to hospital. To investigate the metabolic response to rapid glucose injection in acute malaria, 50 ml of 50% w/v (25 g) dextrose was given over 5 min to 10 adult patients (7 males, 3 females; mean age 30 years) with acute falciparum malaria. Five patients with severe infections were studied between doses of intravenous quinine; 5 cases were uncomplicated and previously untreated. The patients with severe malaria had lower pre-injection plasma glucose concentrations than patients with uncomplicated infections (mean +/- standard deviation, 4.2 +/- 0.9 vs 5.8 +/- 1.1 mmol/litre, 2P less than 0.015). However, peak glucose concentrations (18.6 +/- 4.8 vs 17.0 +/- 2.4 mmol/litre) and integrated responses (AUC0-245 min) were similar in the groups (2P greater than 0.1 in each case), and pre- and post-injection plasma insulin concentrations and AUC0-245 min values were also not significantly different (2P greater than 0.05 in each case). No 'rebound' hypoglycaemia was observed. The patients with severe malaria had higher peak plasma lactate concentrations than the uncomplicated patients (2.5 +/- 0.7 vs 1.5 +/- 0.9 mmol/litre, 2P less than 0.05), but the highest plasma lactate achieved and the greatest maximum post-injection rise were only 3.8 and 0.8 mmol/litre respectively. The average maximum reduction in plasma potassium after injection was 0.2 mmol/litre at 35 min. These data suggest that injections of hypertonic dextrose given empirically in conventional doses to non-acidotic patients with acute, severe malaria are not harmful, but the metabolic response in patients with an established acidosis remains unknown.
first_indexed 2024-03-06T23:47:49Z
format Journal article
id oxford-uuid:718d04c1-2bc1-4f4f-9ed8-aea15fa700b1
institution University of Oxford
language English
last_indexed 2024-03-06T23:47:49Z
publishDate 1991
record_format dspace
spelling oxford-uuid:718d04c1-2bc1-4f4f-9ed8-aea15fa700b12022-03-26T19:44:21ZThe metabolic response to rapid intravenous glucose injection in acute falciparum malaria.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:718d04c1-2bc1-4f4f-9ed8-aea15fa700b1EnglishSymplectic Elements at Oxford1991Pukrittayakamee, SDavis, TLevy, JLooareesuwan, SRoche, RJeerawathanapun, PWhite, NBecause hypoglycaemia is common in severe malaria, intravenous glucose is often given empirically to patients on admission to hospital. To investigate the metabolic response to rapid glucose injection in acute malaria, 50 ml of 50% w/v (25 g) dextrose was given over 5 min to 10 adult patients (7 males, 3 females; mean age 30 years) with acute falciparum malaria. Five patients with severe infections were studied between doses of intravenous quinine; 5 cases were uncomplicated and previously untreated. The patients with severe malaria had lower pre-injection plasma glucose concentrations than patients with uncomplicated infections (mean +/- standard deviation, 4.2 +/- 0.9 vs 5.8 +/- 1.1 mmol/litre, 2P less than 0.015). However, peak glucose concentrations (18.6 +/- 4.8 vs 17.0 +/- 2.4 mmol/litre) and integrated responses (AUC0-245 min) were similar in the groups (2P greater than 0.1 in each case), and pre- and post-injection plasma insulin concentrations and AUC0-245 min values were also not significantly different (2P greater than 0.05 in each case). No 'rebound' hypoglycaemia was observed. The patients with severe malaria had higher peak plasma lactate concentrations than the uncomplicated patients (2.5 +/- 0.7 vs 1.5 +/- 0.9 mmol/litre, 2P less than 0.05), but the highest plasma lactate achieved and the greatest maximum post-injection rise were only 3.8 and 0.8 mmol/litre respectively. The average maximum reduction in plasma potassium after injection was 0.2 mmol/litre at 35 min. These data suggest that injections of hypertonic dextrose given empirically in conventional doses to non-acidotic patients with acute, severe malaria are not harmful, but the metabolic response in patients with an established acidosis remains unknown.
spellingShingle Pukrittayakamee, S
Davis, T
Levy, J
Looareesuwan, S
Roche, R
Jeerawathanapun, P
White, N
The metabolic response to rapid intravenous glucose injection in acute falciparum malaria.
title The metabolic response to rapid intravenous glucose injection in acute falciparum malaria.
title_full The metabolic response to rapid intravenous glucose injection in acute falciparum malaria.
title_fullStr The metabolic response to rapid intravenous glucose injection in acute falciparum malaria.
title_full_unstemmed The metabolic response to rapid intravenous glucose injection in acute falciparum malaria.
title_short The metabolic response to rapid intravenous glucose injection in acute falciparum malaria.
title_sort metabolic response to rapid intravenous glucose injection in acute falciparum malaria
work_keys_str_mv AT pukrittayakamees themetabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT davist themetabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT levyj themetabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT looareesuwans themetabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT rocher themetabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT jeerawathanapunp themetabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT whiten themetabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT pukrittayakamees metabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT davist metabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT levyj metabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT looareesuwans metabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT rocher metabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT jeerawathanapunp metabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria
AT whiten metabolicresponsetorapidintravenousglucoseinjectioninacutefalciparummalaria